摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[[4-(3-methoxylpropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H,5H-imidazo[5,4-f]benzoimidazole | 1322643-89-9

中文名称
——
中文别名
——
英文名称
2-[[4-(3-methoxylpropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H,5H-imidazo[5,4-f]benzoimidazole
英文别名
2-[[4-(3-Methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-3,5-dihydroimidazo[4,5-f]benzimidazole;2-[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-3,5-dihydroimidazo[4,5-f]benzimidazole
2-[[4-(3-methoxylpropoxy)-3-methylpyridin-2-yl]methylsulfanyl]-1H,5H-imidazo[5,4-f]benzoimidazole化学式
CAS
1322643-89-9
化学式
C19H21N5O2S
mdl
——
分子量
383.474
InChiKey
ONMDYJAVLAXGGK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    27
  • 可旋转键数:
    8
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    114
  • 氢给体数:
    2
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Benzimidazole Derivatives And Their Pharmaceutical Compositions And Uses
    申请人:Huang Zhenhua
    公开号:US20130023568A1
    公开(公告)日:2013-01-24
    The present invention relates to benzimidazole derivatives and their pharmaceutical compositions and uses, specifically to benzimidazole derivatives of Formula (I), or their stereoisomer, pharmaceutically acceptable salt or solvates thereof, in which R 1 , R 2 , R 3 , R 4 , R 5 and n have the definitions in the description; the present invention further relates to a pharmaceutical composition containing the compounds, methods for preparing the compounds, and use of the compounds for manufacturing of a medicament for prophylaxis and/or treatment of peptic ulcer, ulcer hemorrhage and diseases associated with gastric acid.
    本发明涉及苯并咪唑衍生物及其制药组合物和用途,具体涉及公式(I)的苯并咪唑衍生物或其立体异构体、药学上可接受的盐或溶剂,其中R1、R2、R3、R4、R5和n在说明书中有定义;本发明还涉及含有该化合物的制药组合物、制备该化合物的方法以及利用该化合物制造用于预防和/或治疗消化性溃疡、溃疡出血和与胃酸有关的疾病的药物的用途。
  • BENZIMIDAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USES
    申请人:Xuanzhu Pharma Co., Ltd.
    公开号:US20160176892A1
    公开(公告)日:2016-06-23
    The present invention relates to benzimidazole derivatives and their pharmaceutical compositions and uses, specifically to benzimidazole derivatives of Formula (I), or their stereoisomer, pharmaceutically acceptable salt or solvates thereof, in which R 1 , R 2 , R 3 , R 4 , R 5 and n have the definitions in the description; the present invention further relates to a pharmaceutical composition containing the compounds, methods for preparing the compounds, and use of the compounds for manufacturing of a medicament for prophylaxis and/or treatment of peptic ulcer, ulcer hemorrhage and diseases associated with gastric acid.
    本发明涉及苯并咪唑衍生物及其制药组合物和用途,具体涉及公式(I)的苯并咪唑衍生物或其立体异构体,其药学上可接受的盐或溶剂,其中R1、R2、R3、R4、R5和n在说明中有定义;本发明还涉及含有该化合物的制药组合物,制备该化合物的方法,以及将该化合物用于制造预防和/或治疗消化性溃疡、溃疡出血和与胃酸有关的疾病的药物的用途。
  • US9315513B2
    申请人:——
    公开号:US9315513B2
    公开(公告)日:2016-04-19
  • BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
    申请人:Xuanzhu Pharma Co., Ltd.
    公开号:EP2532665B1
    公开(公告)日:2016-09-07
查看更多